Silence Therapeutics plc (SLNCF) Net income 2022–2025
Silence Therapeutics plc (SLNCF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$88.6MFY2025 · since FY2022: -$50.3M → -$88.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.6M | -95.6% |
| FY2024 | -$45.3M | +16.4% |
| FY2023 | -$54.2M | -7.7% |
| FY2022 | -$50.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLNCF financial trends
SLNCF RevenueSLNCF Net marginSLNCF Gross profitSLNCF Gross marginSLNCF Operating incomeSLNCF Operating marginSLNCF Operating cash flowSLNCF Free cash flowSLNCF Capital expendituresSLNCF Return on equitySLNCF Stock buybacksSLNCF Dividends paidSLNCF Total assetsSLNCF Total liabilitiesSLNCF Shareholders’ equitySLNCF overview →